Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Miscellaneous and site unspecified neoplasms malignant and unspecified
ADR ID BADD_A02790
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
Description Not Available
MedDRA Code 10027655
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01473Minoxidil--
BADD_D01474Mipomersen sodium--
BADD_D01475Mirabegron--
BADD_D01478Mitomycin0.000112%
BADD_D01479Mitotane--
BADD_D01480Mitoxantrone0.000168%
BADD_D01502Moxifloxacin hydrochloride--
BADD_D01506Muromonab-cd3--
BADD_D01507Mycophenolate mofetil--
BADD_D01508Mycophenolic acid0.001902%
BADD_D01513Nafarelin--
BADD_D01529Nandrolone--
BADD_D01533Naproxen--
BADD_D01549Nelarabine0.000504%
BADD_D01557Nevirapine0.002652%
BADD_D01564Nicotine0.001881%
BADD_D01566Nifedipine--
BADD_D01567Nilotinib0.020136%
BADD_D01572Nitisinone--
BADD_D01585Norethindrone--
BADD_D01590Nuvaring--
BADD_D01592Obeticholic acid0.002606%
BADD_D01595Octreotide acetate--
BADD_D01601Olaparib0.035000%
BADD_D01610Omalizumab--
BADD_D01611Omega-3-acid ethyl esters--
BADD_D01614Omeprazole--
BADD_D01617Ondansetron--
BADD_D01624Orlistat--
BADD_D01629Osimertinib0.038559%
The 9th Page    First    Pre   9 10 11 12 13    Next   Last    Total 18 Pages